Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
Brazil
BOV
Alnylam Pharmaceuticals Inc (A1LN34)
Alnylam Pharmaceuticals Inc (A1LN34) Financials

A1LN34 Alnylam Pharmaceuticals Inc

38.92

0.00 (0.00%)

10 May 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-30.959	-30.138	-42.666	-44.641	-29.585	-24.192	-31.466	-11.937
Return on Equity (%)	-37.54	-36.542	-49.635	-64.664	-69.923	-106.307	-526.144	232.399
Return on Invested Capital (%)	-52.899	-42.702	-53.884	-70.058	-65.765	-61.157	-82.171	-40.288
Operating Margin (%)	-869.628	-545.949	-1015.478	-402.846	-156.457	-83.991	-93.6	-17.081
Net Profit Margin (%)	-869.628	-545.949	-1016.576	-403.238	-174.145	-101.011	-109.036	-24.079
Book Value Per Share	10.708	17.723	12.868	12.824	8.729	4.894	-1.277	-1.758
Earnings Per Share	-4.772	-4.925	-7.526	-7.898	-7.372	-7.096	-9.128	-3.508
Cash Per Share	2.253	6.475	4.153	4.877	4.265	6.823	6.991	6.476
Working Capital Per Share	6.285	16.259	10.093	12.152	17.432	17.581	15.528	16.056
Operating Profit Per Share	0.549	0.902	0.723	1.735	3.563	6.255	7.368	12.526
EBIT Per Share	-4.772	-4.925	-7.518	-7.891	-7.349	-7.09	-9.094	-3.455
EBITDA Per Share	-4.772	-4.925	-7.518	-7.891	-7.349	-7.09	-9.094	-3.455
Free Cash Flow Per Share	-4.132	-3.999	-6.399	-6.797	-7.027	-6.856	-8.905	-3.443

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	5.102	12.234	6.689	4.866	4.468	4.037	3.506	3.082
Quick Ratio	4.759	11.72	6.146	4.479	3.382	3.786	3.165	2.756
Inventory Turnover (Days)	N/A	N/A	117.275	93.593	68.358	37.336	45.373	25.041
Shares Outstanding	85.94M	99.67M	101.18M	112.19M	116.43M	120.18M	123.93M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	120.73M	N/A	N/A	123.93M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-92.373	N/A	N/A	N/A	-44.914	N/A	N/A	N/A
Net Profit Margin (%)	-112.699	N/A	N/A	N/A	-54.528	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	4.274	N/A	N/A	N/A	3.773	N/A	N/A	N/A
Quick Ratio	3.954	N/A	N/A	N/A	3.401	N/A	N/A	N/A
Inventory Turnover (Days)	134.383	N/A	N/A	N/A	150.759	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	18.87B
Price to Earnings Ratio	-42.86
Price to Sales Ratio	10.32
Price to Cash Ratio	23.22
Price to Book Ratio	-85.52
Dividend Yield	-

Share Statistics

Shares Outstanding	125.49M
Average Volume (1 week)	0
Average Volume (1 Month)	5
52 Week Change	-18.92%
52 Week High	51.52
52 Week Low	36.23

More Ratios Coming Soon!

Alnylam Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions